Oxford Asset Management’s PharMerica Corporation PMC Stock Holding History

Oxford Asset Management’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-122,104	Closed	-$3.57M	–	2019
2017 Q3	$3.57M	Buy	+122,104	New	+$3.42M	0.07%	334
2017 Q1	–	Sell	-16,306	Closed	-$410K	–	1543
2016 Q4	$410K	Buy	+16,306	New	+$412K	0.01%	617
2014 Q4	–	Sell	-69,561	Closed	-$1.72M	–	836
2014 Q3	$1.72M	Buy	69,561 +13,112	+23%	+$348K	0.04%	402
2014 Q2	$1.6M	Buy	+56,449	New	+$1.57M	0.05%	422
2014 Q1	–	Sell	-198,168	Closed	-$4.26M	–	835
2013 Q4	$4.26M	Buy	198,168 +14,243	+8%	+$259K	0.11%	269
2013 Q3	$2.44M	Buy	183,925 +107,061	+139%	+$1.44M	0.05%	402
2013 Q2	$1.06M	Buy	+76,864	New	+$1.09M	0.03%	581

Oxford Asset Management's PMC Position: Q4 2017 in Review

Oxford Asset Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 122,104 shares — an estimated $3.57M sold.

Oxford Asset Management first reported a position in PMC in Q2 2013 and held it in 7 quarters. The position peaked at $4.26M in Q4 2013. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

Oxford Asset Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
Oxford Asset Management sold 122,104 PharMerica Corporation shares in Q4 2017, an estimated $3.57M.
Oxford Asset Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 7 quarters.
Oxford Asset Management's PharMerica Corporation position peaked at $4.26M in Q4 2013.
0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Oxford Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.